Far East Pharmaceutical (00512.HK) announces its mid-term performance for 2025: a record high revenue of 6.11 billion Hong Kong dollars, with multiple innovative products demonstrating its development resilience.
Je suis fatigu mais je dois encore travailler.
Latest
3 m ago
